Sporormiella australis (Spegazzini) Ahmed et Cain, teleomorph
商品貨號(hào)
B235129
Strain Designations
MF5672
Application
produces australifungin
Biosafety Level
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
frozen
Storage Conditions
Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section
Type Strain
no
Disclosure
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC.
Cabello A, et al. Antibiotic agents. US Patent 5,276,055 dated Jun 4 1994
Mandala SM, et al. The discovery of australifungin, a novel inhibitor of sphinganine N- acyltransferase from Sporormiella australis. Producing organism, fermentation, isolation, and biological activity. J. Antibiot. 48: 349-356, 1995. PubMed: 7797434
